Therapy of Peptic Ulcer with Semax Peptide

  • I. O. Ivanikov
  • M. E. Brekhova
  • G. E. Samonina
  • N. F. Myasoedov
  • I. P. Ashmarin
Article

DOI: 10.1023/A:1020621124776

Cite this article as:
Ivanikov, I.O., Brekhova, M.E., Samonina, G.E. et al. Bulletin of Experimental Biology and Medicine (2002) 134: 73. doi:10.1023/A:1020621124776

Abstract

Experiments used is combination with traditional preparations (omeprasole, de-nol, and solcoseril), Semax peptide (Met-Glu-His-Phe-Pro-Gly-Pro) possessing nootropic and neuroprotective activity significantly promoted ulcer healing in patients with refractory peptic ulcers. On day 14 of treatment ulcer healing was observed in 89.5% patients receiving intranasal Semax (1% solution, 2-4 drops 3 times a day for 10 days) vs. 30.8% in the control group. Clinical studies of antiulcer activity of Semax in different combinations with usual antiulcer drugs are needed.

Semax peptic ulcer cicatrization period clinical study 

Copyright information

© Plenum Publishing Corporation 2002

Authors and Affiliations

  • I. O. Ivanikov
    • 1
  • M. E. Brekhova
    • 1
  • G. E. Samonina
    • 1
  • N. F. Myasoedov
    • 1
  • I. P. Ashmarin
    • 1
  1. 1.Medical Center of President's Administration, Central Clinical HospitalM. V. Lomonosov Moscow State University; Institute of Molecular Genetics, Russian Academy of SciencesMoscow

Personalised recommendations